Print

MediciNova, Inc. Reports Third Quarter 2012 Results and Update on MN-221 Development  
11/9/2012 9:59:46 AM

SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), yesterday reported financial results for the third quarter ended September 30, 2012 through the filing of its quarterly report on Form 10-Q.
//-->